Form D · Pharmaceuticals

Zeno Pharmaceuticals, Inc.

San Diego, CA · CIK 0001653424

Offering snapshot reported Mar 16, 2016 · SEC filing

Reported sold
$18.3M
Offering amount: $18.3M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 11, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$9.16M$18.3MSep 22, 2015: $15,000,006.00Sep 22, 2015Mar 16, 2016: $18,319,984.00Mar 16, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$15,000,006 → $18,319,984
  • Reported investors1 → 11

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 16, 2016Amendment$18,319,984$3,319,978vs Sep 22, 201511SEC filing
Sep 22, 2015Initial$15,000,006No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-248004

Source: Form D, filed Mar 16, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cam Gallagher Director, Executive
Anthony Y. Sun Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
10835 Road To The Cure, #205
San Diego, CA, 92121